Department of Internal medicine, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Divison of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
PLoS One. 2019 Jul 31;14(7):e0220309. doi: 10.1371/journal.pone.0220309. eCollection 2019.
To estimate time to first optimal glycaemic control and identify prognostic factors among type 2 diabetes mellitus (T2DM) patients attending diabetes clinic of public teaching hospitals in Addis Ababa, Ethiopia.
A retrospective chart review study was conducted at diabetes clinic of Addis Ababa's public teaching hospitals among a randomly selected sample of 685 charts of patients with T2DMwho were on follow up from January 1, 2013 to June 30, 2017. Data was collected using data abstraction tool. Descriptive statistics, Kaplan Meier plots, median survival time, Log-rank test and Cox proportional hazard survival models were used for analysis.
Median time to first optimal glycaemic control among the study population was 9.5 months. Factors that affect time to first optimal glycaemic control were age group (HR = 0.635, 95% CI: 0.486-0.831 for 50-59 years, HR = 0.558, 95% CI: 0.403-0.771for 60-69 years and HR = 0.495, 95% CI: 0.310-0.790 for > = 70 years), diabetes neuropathy (HR = 0.502, 95% CI: 0.375-0.672), more than one complication (HR = 0.381, 95% CI: 0.177-0.816), hypertension (HR = 0.611, 95% CI: 0.486-0.769), dyslipidemia (HR = 0.609, 95% CI: 0.450-0.824), cardiovascular disease (HR = 0.670, 95% CI: 0.458-0.979) and hospital patient being treated (HR = 1.273, 95% CI: 1.052-1.541).
Median time to first optimal glycaemic control among T2DM patients is longer than expected which might imply that patients are being exposed to more risk of complication and death.
评估埃塞俄比亚亚的斯亚贝巴公立教学医院糖尿病门诊 2 型糖尿病(T2DM)患者首次达到最佳血糖控制的时间,并确定其预后因素。
本研究采用回顾性病历研究方法,选取 2013 年 1 月 1 日至 2017 年 6 月 30 日期间在亚的斯亚贝巴公立教学医院糖尿病门诊接受随访的 685 例 T2DM 患者的随机样本进行研究。使用数据提取工具收集数据。采用描述性统计、Kaplan-Meier 图、中位生存时间、Log-rank 检验和 Cox 比例风险生存模型进行分析。
研究人群中首次达到最佳血糖控制的中位时间为 9.5 个月。影响首次达到最佳血糖控制时间的因素包括年龄组(50-59 岁组 HR = 0.635,95%CI:0.486-0.831;60-69 岁组 HR = 0.558,95%CI:0.403-0.771;≥70 岁组 HR = 0.495,95%CI:0.310-0.790)、糖尿病神经病变(HR = 0.502,95%CI:0.375-0.672)、并发症≥1 种(HR = 0.381,95%CI:0.177-0.816)、高血压(HR = 0.611,95%CI:0.486-0.769)、血脂异常(HR = 0.609,95%CI:0.450-0.824)、心血管疾病(HR = 0.670,95%CI:0.458-0.979)和住院患者(HR = 1.273,95%CI:1.052-1.541)。
T2DM 患者首次达到最佳血糖控制的中位时间长于预期,这可能意味着患者面临更高的并发症和死亡风险。